Trillium Therapeutics gets Canada, HSR approval for sale to Pfizer

seekingalpha2021-11-17

Trillium Therapeutics(NASDAQ:TRIL)disclosed that applicable waiting periods under the Competition Act in Canada and HSR in the U.S. expired on Monday in regards to its $2.3B sale to Pfizer (NYSE:PFE)....

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

Jjjjia
2021-11-17
Jjjjia
Like pls
- Pplymm:
  Done. Pls like back thanks
JimmyLZH
2021-11-17
JimmyLZH
👍🏻
小白添祥
2021-11-17
小白添祥
like & comment please
- Pplymm:
  Done. Pls like back thanks
njkk
2021-11-17
njkk
Pls like
- 小白添祥:
  like & comment please

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/1142236545?lang=zh_CN&edition=full","thumbnail":"","is_english":true,"pubTime":"2021-11-17 09:38","share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","id":"1142236545","market":"us","top_or_hot":-1,"title":"Trillium Therapeutics gets Canada, HSR approval for sale to Pfizer","media":"seekingalpha","content":"<div>\n<p>Trillium Therapeutics(NASDAQ:TRIL)disclosed that applicable waiting periods under the Competition Act in Canada and HSR in the U.S. expired on Monday in regards to its $2.3B sale to Pfizer (NYSE:PFE)....</p>\n\n<a href=\"https://seekingalpha.com/news/3771714-trillium-therapeutics-gets-canada-hsr-approval-for-sale-to-pfizer\">网页链接</a>\n\n</div>\n","source":"seekingalpha","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Trillium Therapeutics gets Canada, HSR approval for sale to Pfizer</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTrillium Therapeutics gets Canada, HSR approval for sale to Pfizer\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-17 09:38 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3771714-trillium-therapeutics-gets-canada-hsr-approval-for-sale-to-pfizer><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Trillium Therapeutics(NASDAQ:TRIL)disclosed that applicable waiting periods under the Competition Act in Canada and HSR in the U.S. expired on Monday in regards to its $2.3B sale to Pfizer (NYSE:PFE)....</p>\n\n<a href=\"https://seekingalpha.com/news/3771714-trillium-therapeutics-gets-canada-hsr-approval-for-sale-to-pfizer\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TRIL","symbol_name":"Trillium Therapeutics Inc.","start_time":0,"source_url":"https://seekingalpha.com/news/3771714-trillium-therapeutics-gets-canada-hsr-approval-for-sale-to-pfizer","article_id":"1142236545","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1142236545","pubTimestamp":1637113135,"sourceInfo":{"source_id":"seekingalpha","name":"Seeking Alpha"},"weMediaInfo":null,"summary":"Trillium Therapeutics(NASDAQ:TRIL)disclosed that applicable waiting periods under the Competition Ac","collect":0,"end_time":0,"defaultTopTitle":"seekingalpha.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"TRIL":"Trillium Therapeutics Inc.","PFE":"辉瑞"},"translate_title":"延龄草疗法获得加拿大高铁批准出售给辉瑞","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PFE":0.9,"TRIL":0.9},"content_text":"Trillium Therapeutics(NASDAQ:TRIL)disclosed that applicable waiting periods under the Competition Act in Canada and HSR in the U.S. expired on Monday in regards to its $2.3B sale to Pfizer (NYSE:PFE).\nThe closing of the transaction is expected to occur on or about tomorrow, according to an 8-K filing.\nEarlier, Trillium Therapeutics gains quickly after Nasdaq delisting notice on Pfizer.\nIn late August Pfizer agreed to buy Trillium, a clinical stage immuno-oncology company, in a $2.3B deal. Under the terms of the agreement, Pfizer agreed to buy Trillium for an implied $18.50/share, in cash.\nThe delisting notices comes as Trillium's HSR deadline for the Pfizer deal was scheduled to expire.","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":871749587,"gmtCreate":1637116000460,"gmtModify":1637116001013,"author":{"id":"4087709618925430","authorId":"4087709618925430","name":"Jjjjia","avatar":"https://static.tigerbbs.com/25215d9b4b22838734cba07948cafe46","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"4087709618925430","authorIdStr":"4087709618925430"},"htmlText":"Like pls","listText":"Like pls","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/871749587","repostId":1142236545,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6610131,"gmtCreate":1637117565218,"gmtModify":1637117565253,"authorId":3582681835792049,"author":{"id":3582681835792049,"idStr":"3582681835792049","authorId":3582681835792049,"name":"Pplymm","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":871749587,"type":1,"supId":0,"prevId":0,"content":"Done. Pls like back thanks","text":"Done. Pls like back thanks","html":"Done. Pls like back thanks"}],"langContent":"CN"},{"id":871727098,"gmtCreate":1637114877600,"gmtModify":1637114877802,"author":{"id":"3586863844711073","authorId":"3586863844711073","name":"JimmyLZH","avatar":"https://static.tigerbbs.com/7ecc6de8a47b65c54bcbdca5fe23b697","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3586863844711073","authorIdStr":"3586863844711073"},"htmlText":"👍🏻","listText":"👍🏻","text":"👍🏻","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/871727098","repostId":1142236545,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":871722495,"gmtCreate":1637114654219,"gmtModify":1637114836177,"author":{"id":"3571345352614779","authorId":"3571345352614779","name":"小白添祥","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"3571345352614779","authorIdStr":"3571345352614779"},"htmlText":"like &amp; comment please&nbsp;","listText":"like &amp; comment please&nbsp;","text":"like & comment please","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/871722495","repostId":1142236545,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6610135,"gmtCreate":1637117570563,"gmtModify":1637117570592,"authorId":3582681835792049,"author":{"id":3582681835792049,"idStr":"3582681835792049","authorId":3582681835792049,"name":"Pplymm","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":871722495,"type":1,"supId":0,"prevId":0,"content":"Done. Pls like back thanks","text":"Done. Pls like back thanks","html":"Done. Pls like back thanks"}],"langContent":"CN"},{"id":871722996,"gmtCreate":1637114596365,"gmtModify":1637114771201,"author":{"id":"3575950181915531","authorId":"3575950181915531","name":"njkk","avatar":"https://static.tigerbbs.com/6382201e8e84ccd3f8e89b9a28e74607","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3575950181915531","authorIdStr":"3575950181915531"},"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/871722996","repostId":1142236545,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6609437,"gmtCreate":1637114660777,"gmtModify":1637114660817,"authorId":3571345352614779,"author":{"id":3571345352614779,"idStr":"3571345352614779","authorId":3571345352614779,"name":"小白添祥","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":871722996,"type":1,"supId":0,"prevId":0,"content":"like &amp; comment please ","text":"like &amp; comment please ","html":"like &amp; comment please "}],"langContent":"CN"}],"isCommentEnd":false,"newsSizeData":{"likeSize":59,"commentSize":4,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1142236545"}